1 Min Read
* CEO SAYS “WE DON’T BELIEVE ANY ADDITIONAL CLINICAL TRIALS ARE NECESSARY” ON CONF CALL WHEN ASKED ABOUT FDA’S DECISION ON ITS DEPRESSION DRUG Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.